News & Articles

Industry experts discuss the role of artificial intelligence in the fight against COVID-19, the lessons learned and its future promise in healthcare

Keep up to date with the latest technologies and techniques advancing clinical diagnostics

The CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for TIBSOVO

PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify esophageal cancer patients for treatment with KEYTRUDA (pembrolizumab)

QIAreach SARS-CoV-2 Antigen Test, developed in collaboration with Ellume, provides accurate and objective results in 2 to 15 minutes

Obtaining two vaccine doses remains the most effective way to ensure protection against the COVID-19 Delta variant

Patients with underlying heart problems are more than four times as likely to die from COVID-19

Low-cost device lets consumers check themselves for multiple strains of SARS-CoV-2 at home

The fully automated CN-3000 and CN-6000 Systems bring mid- and high-volume coagulation testing to laboratories

The Amulet is the first and only minimally invasive treatment option to offer immediate closure of the left atrial appendage, so blood-thinning medication isn't needed following implantation

The new intuitive interface provides step-by-step guidance to enhance ease of use

Gain insight into how syndromic testing can improve pathogen detection, lead to better-informed treatment plans, and aid antimicrobial stewardship

Gain insights on hot topics ranging from SARS-CoV-2 variants to the fundamentals of fluorescence and confocal microscopy

Scientists at University of Warwick demonstrate that levels of a protein – TPD54 – affect movement of cells

Researchers found that longer dosing intervals led to higher antibody levels and a higher proportion of ‘helper’ T cells

Findings explain higher risk of heart attack in people with diabetes, even after treatment

The drug aims to treat patients with myelodysplastic syndromes

Immune repertoire assays offer high detection rates of malignant clones, empowering researchers to better assess blood cancers